Company intelligence / Profile preview

Eyedea Medical

Baltimore, Maryland, United Stateseyedeamedical.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Eyedea Medical develops innovative ophthalmic medical devices to improve efficiency, quality, and accessibility in corneal transplants. The company has received competitive grant funding (including from the National Science Foundation) to support its work addressing global corneal blindness. Its technologies are designed for use by patients, specialists, and eye banks. No clinical trial results or commercial product launches have been reported as of June 2025.

Therapeutic areas: Ophthalmology
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

National Science Foundation (grant funding partner)Johns Hopkins University (investor/supporter)

Beyond the preview

Go deeper on Eyedea Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eyedea Medical.

Explore the full profile